CALCIUM INHIBITION OF THE ACTIVATION OF PROTEIN-C BY THROMBIN ROLE OF THE P3 AND P3' RESIDUES

被引:6
|
作者
REZAIE, AR
ESMON, CT
机构
[1] OKLAHOMA MED RES FDN,CARDIOVASC BIOL RES PROGRAM,OKLAHOMA CITY,OK 73104
[2] UNIV OKLAHOMA,HLTH SCI CTR,DEPT PATHOL,OKLAHOMA CITY,OK
[3] UNIV OKLAHOMA,HLTH SCI CTR,DEPT BIOCHEM & MOLEC BIOL,OKLAHOMA CITY,OK 73190
[4] HOWARD HUGHES MED INST,OKLAHOMA CITY,OK
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1994年 / 223卷 / 02期
关键词
D O I
10.1111/j.1432-1033.1994.tb19027.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein C, a precursor to a natural plasma anticoagulant, and the platelet thrombin receptor, involved in cell activation, both require proteolytic cleavage to be activated. In humans, the sequences adjacent to the scissile bond of protein C, DPR/LID and the thrombin receptor DPR/SFL are similar. Previous studies with Asp-->Gly mutants indicated that both the P3 and the P3' Asp residues make either peptides or protein C a poor substrate for free thrombin, but thrombin interaction with thrombomodulin overcomes these inhibitory interactions. Similar mechanisms are probably operative in the thrombin receptor. In rodents, the P3 Asp residue of the human thrombin receptor is replaced by Asn and in protein C, the P3' residue is Asn. To determine the functional significance of these Asp-->Asn substitutions, the Asp in the P3 or P3' position of human protein C was changed to Asn. The resultant mutants were still resistant to activation by thrombin, and still required Ca2+ for activation by thrombin-thrombomodulin complex. We conclude that, unlike activation of the Asp-->Gly mutants by thrombin, activation of the P3 and P3' Asp-->Asn mutants is still potently inhibited by physiological Ca2+. Furthermore, even though the charge has been deleted, thrombomodulin acceleration is retained.
引用
收藏
页码:575 / 579
页数:5
相关论文
共 50 条
  • [1] CHARGE REVERSAL AT THE P3' POSITION IN PROTEIN-C OPTIMALLY ENHANCES THROMBIN AFFINITY AND ACTIVATION RATE
    RICHARDSON, MA
    GERLITZ, B
    GRINNELL, BW
    [J]. PROTEIN SCIENCE, 1994, 3 (04) : 711 - 712
  • [2] P3 AND (DE)ACTIVATION
    ROTH, WT
    FORD, JM
    [J]. BEHAVIORAL AND BRAIN SCIENCES, 1988, 11 (03) : 393 - 394
  • [3] P3
    [J]. HSB International, 1998, 47 (07):
  • [4] Design of P1′ and P3′ residues of trivalent thrombin inhibitors and their crystal structures
    Sion-Usakiewicz, JJ
    Sivaraman, J
    Li, YG
    Cygler, M
    Konishi, Y
    [J]. BIOCHEMISTRY, 2000, 39 (09) : 2384 - 2391
  • [5] Somatosensory P3 and auditory P3 in relation to reaction time
    Ito, J
    [J]. RECENT ADVANCES IN EVENT-RELATED BRAIN POTENTIAL RESEARCH, 1996, 1099 : 139 - 142
  • [6] A RIGIDITY THEOREM FOR P3(C)
    PETERNELL, T
    [J]. MANUSCRIPTA MATHEMATICA, 1985, 50 (1-3) : 397 - 428
  • [7] Hyperbolic surfaces in P3(C)
    Khoai, HH
    [J]. PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY, 1997, 125 (12) : 3527 - 3532
  • [8] NEW TRIPEPTIDIC THROMBIN INHIBITORS - INFLUENCE OF P2 AND P3 RESIDUES ON ACTIVITY AND SELECTIVITY
    DENANTEUIL, G
    GLOANEC, P
    LILA, C
    PORTEVIN, B
    BOUDON, A
    RUPIN, A
    VERBEUREN, TJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (08) : 1019 - 1024
  • [9] NOVELTY AND THE P3
    VERBATEN, MN
    [J]. BEHAVIORAL AND BRAIN SCIENCES, 1988, 11 (03) : 397 - 399
  • [10] THE P3 PARADOX
    Haake, Daniel G.
    [J]. ITE JOURNAL-INSTITUTE OF TRANSPORTATION ENGINEERS, 2018, 88 (02): : 16 - 17